Ticker Details
Harmony Biosciences Holdings, Inc.
IPO Date:	August 19, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.69B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.76 | 2.07%
Avg Daily Range (30 D):	$0.34 | 1.20%
Avg Daily Range (90 D):	$0.55 | 1.60%

Institutional Daily Volume
Avg Daily Volume:	.44M
Avg Daily Volume (30 D):	.54M
Avg Daily Volume (90 D):	.64M

Trade Size
Avg Trade Size (Sh.):	52
Avg Trade Size (Sh.) (30 D):	46
Avg Trade Size (Sh.) (90 D):	51

Institutional Trades
Total Institutional Trades:	2,146
Avg Institutional Trade:	$2.38M
Avg Institutional Trade (30 D):	$3.18M
Avg Institutional Trade (90 D):	$2.97M
Avg Institutional Trade Volume:	.07M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$3M
Avg Closing Trade (30 D):	$3.97M
Avg Closing Trade (90 D):	$4.03M
Avg Closing Volume:	84.35K

News

Feb 1, 2026 @ 3:19 AM Harmony Biosciences' CFO Sells All of Her Insider ... Source: Adé Hennis

Jan 27, 2026 @ 5:02 PM Harmony Biosciences' Sales and Profits Have Soared... Source: Dan Caplinger

Apr 8, 2025 @ 5:00 PM Developmental and Epileptic Encephalopathies Marke... Source: Delveinsight

Jan 22, 2025 @ 6:00 PM 5-HT2 Agonist Clinical Trial Pipeline Appears Robu... Source: Delveinsight

Dec 19, 2024 @ 6:00 PM Comprehensive Market Analysis of Latest Published ... Source: Delveinsight

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$2.76	$.4	$2.76
Diluted EPS	$2.71	$.39	$2.71
Revenue	$868.45M	$243.78M	$868.45M
Gross Profit	$670.11M	$175.23M	$670.11M
Net Income / Loss	$158.69M	$22.49M	$158.69M
Operating Income / Loss	$208.47M	$38.56M	$208.47M
Cost of Revenue	$198.34M	$68.55M	$198.34M
Net Cash Flow	$299.5M	$105.5M	$299.5M
PE Ratio	10.15